John joined Delphi Ventures as a General Partner in 2003 and focuses on medical device and diagnostic investments.

Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007. From 1988 to 1997, John held a variety of senior management positions including President and General Manager at EP Technologies, Vice President of Operations at both Boston Scientific Corporation and Cardiovascular Imaging Systems (CVIS). While at CVIS, John was a key member of the senior management team during the Company's IPO and eventual acquisition by Boston Scientific Corporation. John also serves on the Advisory Board for the School of BioMedical Engineering at UC Davis.

EDUCATION

• B.S. Mechanical Engineering, University of California, Davis

REPRESENTATIVE BOARD INVOLVEMENT

• Acclarent, Inc. a.b. Ethicon Inc., a Johnson & Johnson company (JNJ)
• Aragon Surgical, Inc.
• EBR Systems, Inc.
• EndoTex Interventional Systems, Inc. a.b. Boston Scientfic Corp. (BSX)
• Lutonix, Inc. a.b. C.R. Bard, Inc. (BCR)
• NeuroVista, Inc.
• Pivot Medical, Inc.
• VytronUS, Inc.